Incanthera Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Incanthera Ltd (Incanthera) is a drug development and targeted cancer medicines company that discovers and develops novel treatments for solid tumours. The companys pipeline drug candidates include ICT01-2588, a vascular disrupting agent, based on the tumor-blasting technology; ICT03 Es5, a potent bioreductive anticancer agent, which are targeted at destroying all forms of solid tumors; ICT04-CYP, that target on colorectal cancer. Incanthera assists the commercialization of the drug development and licensing these to large pharmaceutical companies. The company provides technology and products in the field of oncology and diagnostics. It operates research laboratory in Bradford, West Yorkshire. Incanthera is headquartered in Manchester, the UK.

Incanthera Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Incanthera Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Incanthera Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Incanthera Acquires Drug Development Programme from University of Bradford 10
Venture Financing 11
Incanthera Raises USD2 Million in Financing Round 11
Incanthera Raises US$1 Million In Venture Financing 12
Incanthera Raises US$0.6 Million In Venture Financing 13
Partnerships 14
ImmuPharma to Enter into Partnership with Incanthera 14
Licensing Agreements 15
Incanthera Enters into Licensing Agreement for ICT01-2588 15
Acquisition 16
Incanthera Acquires Spear Therapeutics 16
Incanthera Acquires Onco-NX, Drug Discovery Company 17
Incanthera Ltd - Key Competitors 18
Incanthera Ltd - Key Employees 19
Incanthera Ltd - Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List Of Tables


Incanthera Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Incanthera Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Incanthera Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Incanthera Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Incanthera Acquires Drug Development Programme from University of Bradford 10
Incanthera Raises USD2 Million in Financing Round 11
Incanthera Raises US$1 Million In Venture Financing 12
Incanthera Raises US$0.6 Million In Venture Financing 13
ImmuPharma to Enter into Partnership with Incanthera 14
Incanthera Enters into Licensing Agreement for ICT01-2588 15
Incanthera Acquires Spear Therapeutics 16
Incanthera Acquires Onco-NX, Drug Discovery Company 17
Incanthera Ltd, Key Competitors 18
Incanthera Ltd, Key Employees 19
Incanthera Ltd, Other Locations 20
Incanthera Ltd, Subsidiaries 20

List Of Figures


Xinjiang Goldwind Science & Technology Co Ltd, Performance Chart (2013 - 2017) 31
Xinjiang Goldwind Science & Technology Co Ltd, Ratio Charts 33
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals By Year, 2012 to YTD 2018 34
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals by Type, 2012 to YTD 2018 35

Incanthera Ltd - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Incanthera Ltd (Incanthera) is a drug development and targeted cancer medicines company that discovers and develops novel treatments for solid tumours. The companys pipeline drug candidates include ICT01-2588, a vascular

USD 250 View Report

Incanthera Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Incanthera Ltd (Incanthera) is a drug development and targeted cancer medicines company that discovers and develops novel treatments for solid tumours. The companys pipeline drug candidates include ICT01-2588, a vascular

USD 250 View Report

Daisy IT Group Ltd - Strategic SWOT Analysis Review

Daisy IT Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis,

USD 125 View Report

Vivergo Fuels Ltd - Strategic SWOT Analysis Review

Vivergo Fuels Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available